REGULAR FORMOTEROL TREATMENT IN MILD ASTHMA - EFFECT ON BRONCHIAL RESPONSIVENESS DURING AND AFTER TREATMENT

被引:99
作者
YATES, DH
SUSSMAN, HS
SHAW, MJ
BARNES, PJ
CHUNG, KF
机构
[1] NATL HEART & LUNG INST,DEPT THORAC MED,LONDON SW3 6LY,ENGLAND
[2] CIBA GEIGY PHARMACEUT CORP,HORSHAM RH12 4AB,W SUSSEX,ENGLAND
关键词
D O I
10.1164/ajrccm.152.4.7551366
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Regular beta(2)-adrenoceptor agonist therapy may lead to a rebound increase in bronchial responsiveness on discontinuation of therapy and a reduction in bronchoprotective effects. Formoterol, a long-acting beta(2)-agonist, is effective in single doses in the prevention of methacholine-induced bronchoconstriction. In a double-blind, placebo-controlled cross-over study, we examined the effect of an inhaled long-acting beta(2)-adrenoceptor agonist, formoterol (24 mu g twice a day) for 2 wk on airway function and responsiveness in 17 subjects with mild asthma (mean age, 26.3 +/- 1.4 yr) who were not taking inhaled glucocorticosteroids. FEV(1) and the provocative concentration of methacholine causing a 20% fall in FEV(1) (PC20) were measured at 36, 60, and 108 h and at 2 wk after the last dose of regular treatment. In addition, PC20 was measured 12 h after the first and the last dose of formoterol and placebo. PC20 values at 36, 60, 108 h and at 2 wk after formoterol treatment cessation were not significantly different from those after placebo. Mean FEV(1) was 3.44 +/- 0.18 L after placebo compared with 3.79 +/- 0.20 L after formoterol (p < 0.001) 12 h after the first dose, and mean PC20 was 0.53 (GSEM 1.4) mg/ml after placebo compared with 2.0 (GSEM 1.4) mg/ml after formoterol (p < 0.001). After 2 wk of regular treatment, mean FEV(1) at 12 h after the final dose of formoterol fell to 3.51 +/- 0.23 L compared with 3.41 +/- 0.18 L after the final dose of placebo (p = 0.03). Mean PC20 increased to 0.77 (GSEM 1.3) mg/ml after the final dose of formoterol, but this was a reduction in the protective effect of the first dose of formoterol compared with placebo (95% confidence interval for treatment difference: 0.19 to 0.95 mg/ml; p = 0.04). These observations indicate that formoterol can be discontinued after 2 wk of treatment without rebound hyperresponsiveness but that its bronchodilator and bronchoprotective effects are reduced.
引用
收藏
页码:1170 / 1174
页数:5
相关论文
共 39 条
  • [1] ARVIDSSON P, 1991, EUR RESPIR J, V4, P1168
  • [2] BARNES PJ, 1993, EUR RESPIR J, V5, P1126
  • [3] EFFECT ON AIRWAY RESPONSIVENESS OF 6 WEEKS TREATMENT WITH SALMETEROL
    BEACH, JR
    YOUNG, CL
    HARKAWAT, R
    GARDINER, PV
    AVERY, AJ
    COWARD, GA
    WALTERS, EH
    HENDRICK, DJ
    [J]. PULMONARY PHARMACOLOGY, 1993, 6 (02): : 155 - 157
  • [4] FORMOTEROL, A NEW LONG-ACTING SELECTIVE BETA2-ADRENERGIC RECEPTOR AGONIST - DOUBLE-BLIND COMPARISON WITH SALBUTAMOL AND PLACEBO IN CHILDREN WITH ASTHMA
    BECKER, AB
    SIMONS, FER
    MCMILLAN, JL
    FARIDY, T
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (06) : 891 - 895
  • [5] CHANGES IN METHACHOLINE-INDUCED BRONCHOCONSTRICTION WITH THE LONG-ACTING BETA(2) AGONIST SALMETEROL IN MILD-TO-MODERATE ASTHMATIC-PATIENTS
    BOOTH, H
    FISHWICK, K
    HARKAWAT, R
    DEVEREUX, G
    HENDRICK, DJ
    WALTERS, EH
    [J]. THORAX, 1993, 48 (11) : 1121 - 1124
  • [6] LONG-TERM EFFECTS OF A LONG-ACTING BETA-2-ADRENOCEPTOR AGONIST, SALMETEROL, ON AIRWAY HYPERRESPONSIVENESS IN PATIENTS WITH MILD ASTHMA
    CHEUNG, D
    TIMMERS, MC
    ZWINDERMAN, AH
    BEL, EH
    DIJKMAN, JH
    STERK, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) : 1198 - 1203
  • [7] COCKROFT DW, 1993, LANCET, V432, P833
  • [8] USE OF EXERCISE CHALLENGE TO INVESTIGATE POSSIBLE TOLERANCE TO BETA-ADRENOCEPTOR STIMULATION IN ASTHMA
    GIBSON, GJ
    GREENACRE, JK
    KONIG, P
    CONOLLY, ME
    PRIDE, NB
    [J]. BRITISH JOURNAL OF DISEASES OF THE CHEST, 1978, 72 (03): : 199 - 206
  • [9] GRAAFLONNEVIG V, 1990, CLIN EXP ALLERGY, V20, P429
  • [10] PROTECTIVE EFFECT AND DURATION OF ACTION OF INHALED FORMOTEROL AND SALBUTAMOL ON EXERCISE-INDUCED ASTHMA IN CHILDREN
    HENRIKSEN, JM
    AGERTOFT, L
    PEDERSEN, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (06) : 1176 - 1182